return to small text site

 

US
Europe
US
Europe

press releases

press coverage
electronic press kit
LX211
LX201

LX214

LX212
polymer technology
pipeline
other projects

uveitis

corneal transplantation
dry eye syndrome

age-related macular degeneration

mission
history
management
board of directors
investors

About

Ophthalmic Indications
Products &
Technologies

Partners

News & Media
Careers
Contact Us

 

  MISSION
 

Mission Statement
Lux Biosciences is dedicated to the identification, optimization, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases.

Identification
We license ophthalmic rights to proprietary molecules and technologies from academic and corporate partners. Generally, these have previously demonstrated proof-of-concept in related non-ophthalmic diseases. Hence, we leverage common biological mechanisms and pathways to accelerate the development of novel medications for ophthalmic indications.

Optimization
We develop novel products based on delivery of medications to the eye utilizing proprietary formulations and technologies.

Development
We develop our product candidates and gain approval in international markets.

Commercialization
We will market ophthalmic products worldwide through our own sales organization and through commercial collaborations. Lux Biosciences' formulations and products are patented and/or patent pending in the U.S. and foreign countries.

 

© 2008 Lux Biosciences, Inc. All rights reserved.                 Web Terms